Study to Assess to Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole
Phase: 2/3
Status: Ongoing
Details
MACrO2 – A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Prospective Study to Assess to Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with treatment-Refractory Mycobacterium avium Complex Lung Disease – Protocol EBO-301
Sponsor: AN2 Therapeutics
IRB#: 2022-029